Revealed evidence derived from clinical trials assessing the efficacy and security of CBD in sufferers with gastrointestinal Diseases remains scarce. That point led Dr. Camilleri and Mayo Clinic colleagues to carry out a randomized managed demo investigating the usage of CBD in individuals with